Over five percent of the medical patients visiting hospitals is to accident and emergency care departments. About 40 percent of those cases are related to chest pain complications. All those people with chest pain complications had to stay up to 20 hours at the hospitals to undergo expensive heart disease tests. But about 75 percent of them found not to be with any serious heart disease condition.
Researchers from the Creavo Medical Technologies, a United Kingdom based company have developed a battery operated and portable VitalScan device based on disease detection technology. The device can read, display and store heart's (cardiac) electromagnatic variations. The product can perform a quick scan (within five minutes) for the signs of heart diseases in a person and can save time and patient's healthcare costs.
This innovative device uses magnetocardiography (MCG) technology and noise-reduction algorithm to map or scan the magnetic fields of the hearts extremely small electrical signals (impulses). Even a slight disruption in the heart's function caused due to heart disease events (for example ischaemic heart disease) will distort the heart's magnetic field. The distortions in the heart's magnetic field can be seen clearly in the scan or map of this innovative device.
This device enables heart care specialists in identifying heart diseases accurately in a patient quickly. The patient can save time and money. The patient can be moved for the appropriate treatment other than heart diseases. Clinical trials of this non-invasive product are being conducted in the United Kingdom. The United States Food and Drug Administration has given clearances to conduct clinical trials in the United States. The product is going to be tested in emergency care departments in hospitals in the United States.
Heart diseases mainly affect men as around two-thirds of patients admitted to the hospitals after the heart attack are being men. But women suffer different type of heart attack and they are at higher risk of death within a year after suffering a heart attack. This is because women suffer from diffuse coronary artery disease (widespread disease or damage in the coronary arteries) and surgical procedures may not be successful in treating them. The heart attack women patient also likely to be a diabetes patient with an average age of heart attack women patient tend to be higher over men by 10 years. Another important likely risk factor for women in addition to diabetes is depression.
A study done by researchers at the Technical University of Munich (TUM), Germany shows enhanced risk of death in women compared to men during the first year after surviving the heart attack. Researchers have analyzed data of nearly 4,100 participants. Researchers found 1.5 times higher death risk within 365 days after having a heart attack among women compared to men with similar heart disease histories. Authors of the study say healthcare professionals should provide intensive support to women heart attack patients, especially in the first year after the heart attack event.
Author of the study was Professor Georg Schmidt, a cardiologist and also Head of Biosignal Analysis Working Group, Technical University of Munich (TUM), Germany. The study findings were published October 20, 2017 in the journal PLOS ONE.
Citation: Ubrich R, Barthel P, Haller B, Hnatkova K, Huster KM, Steger A, et al. (2017) Sex differences in long-term mortality among acute myocardial infarction patients: Results from the ISAR-RISK and ART studies. PLoS ONE 12(10): e0186783.
The Diabetes News Chronicle does not provide medical advice, diagnosis or treatment. Information in Diabetes News Chronicle is to support and not to replace medical advice given by the surgeon or physician or doctor. Published article is not a medical advice by the OWNER of "Diabetes News Chronicle" website or by the AUTHOR of the article.
Published by Jammi Vasista, Chennai, India.